Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Release Date: February 7, 2025

Expiration Date: February 7, 2026

Activity Overview

This online, on-demand virtual symposium brings together renowned experts the treatment of psychiatric disorders. In this educational program, these experts discuss best practices for managing a multitude of psychiatric diagnoses, including major depressive disorder, substance use disorders, bipolar, schizophrenia, ADHD and many more. Emerging treatments and data from ongoing clinical trials that may impact clinical practice in the near future are also be addressed.

This educational activity is an archive of the live symposium held on January 17, 2025.

Target Audience

This educational activity is directed toward advanced practice professionals (APPs) on the front

lines of care who treat psychiatric disorders in both outpatient and inpatient settings. Other health care professionals interested in the treatment of psychiatric disorders are also invited to participate to further enhance knowledge of current psychiatric treatment options.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe the mechanism of action and pharmacologic profile (ie, onset of action, half-life, and steady state) of pharmacotherapeutics used to treat psychiatric disorders
• Assess the clinical use profiles of pharmacotherapeutics used to treat psychiatric disorders
• Identify how to position current treatment options for patients based on drug characteristics, patient needs, and consideration of fiscal obtainability

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.